Health Care Equipment

Know Labs

Know Labs Inc. renamed to USBC, Inc.

Know Labs released FY2025 Q3 earnings on August 5 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.55 (forecast USD -2.4)

Know Labs released FY2025 9 Months Earnings on August 5 (EST) with actual revenue of USD 0 and EPS of USD -3.5194

Jane Street and Ingalls Snyder Invest in Know Labs

Know Labs Inc Acquired by Goldeneye 1995 LLC

Greg Kidd Acquires Controlling Stake in Know Labs Inc.

Know Labs Shares Rise As Jane Street Buys In

Know Labs released FY2025 Semi-Annual earnings on May 14, 2025 (EST) with actual revenue USD 0 and EPS USD -2.9542

Know Labs released FY2025 Q2 earnings on May 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.238 (forecast USD -2.4)

Know Labs released FY2025 Q1 earnings on February 14 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -1.7325 USD (forecast -2 USD)

Know Labs Launches Structured Customer Engagement Process for KTL

Know Labs Launches KTL Technology Licensing to Commercialize RFDS Technology

Know Labs released FY2024 Q4 earnings on November 14 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -1.5307 USD (forecast -2 USD)

Know Labs released FY2024 Annual Earnings on November 14 (EST), with actual revenue of 0 USD and actual EPS of -7.8519 USD (forecast EPS was -8.4 USD)

Know Labs released FY2024 9 Months Earnings on August 14 (EST), with actual revenue of 0 USD and EPS of -6.445 USD

Know Labs released FY2024 Q3 earnings on August 14 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -2.0248 USD (forecast -2.4 USD)

Know Labs Inc Announces $3.445 Million Public Offering at $0.26 per Unit

Know Labs, Inc. published a study on non-invasive blood glucose monitoring devices in the Journal of Diabetes Technology & Therapeutics

Know Labs released FY2024 Q2 earnings on May 15 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -2.6887 USD (forecast -2 USD)

Know Labs released FY2024 Semi-Annual Earnings on May 15 (EST) with actual revenue of 0 USD and EPS of -4.4242 USD

flyExclusive

Creative Global Tech

Pineapple Financial

Enliven Therapeutics

AgEagle Aerial

Murano Global BV

Aclarion

Century Therapeutics

Nuvve

Ping An Biomedical

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Know Labs(KNW.US)